3-Trifluoromethylpyrazolones derived nucleosides: Synthesis and antiviral evaluation.
Identifieur interne : 000D74 ( Main/Exploration ); précédent : 000D73; suivant : 000D753-Trifluoromethylpyrazolones derived nucleosides: Synthesis and antiviral evaluation.
Auteurs : Ayman M S. Ahmed [Égypte] ; Reham A I. Abou-Elkhair [Égypte] ; Alaa M. El-Torky [Égypte] ; Abdalla E A. Hassan [Égypte]Source :
- Nucleosides, nucleotides & nucleic acids [ 1532-2335 ] ; 2019.
Descripteurs français
- KwdFr :
- Antiviraux (pharmacologie), Antiviraux (synthèse chimique), Conception de médicament, Coronavirus du syndrome respiratoire du Moyen-Orient (), Hepacivirus (), Humains, Influenzavirus A (), Nucléosides (pharmacologie), Nucléosides (synthèse chimique), Pyrazolones (), Relation structure-activité, Réplication virale (), Structure moléculaire, Virus de l'hépatite B (), Virus de la dengue (), Virus respiratoires syncytiaux ().
- MESH :
- pharmacologie : Antiviraux, Nucléosides.
- synthèse chimique : Antiviraux, Nucléosides.
- Conception de médicament, Coronavirus du syndrome respiratoire du Moyen-Orient, Hepacivirus, Humains, Influenzavirus A, Pyrazolones, Relation structure-activité, Réplication virale, Structure moléculaire, Virus de l'hépatite B, Virus de la dengue, Virus respiratoires syncytiaux.
English descriptors
- KwdEn :
- Antiviral Agents (chemical synthesis), Antiviral Agents (pharmacology), Dengue Virus (drug effects), Drug Design, Hepacivirus (drug effects), Hepatitis B virus (drug effects), Humans, Influenzavirus A (drug effects), Middle East Respiratory Syndrome Coronavirus (drug effects), Molecular Structure, Nucleosides (chemical synthesis), Nucleosides (pharmacology), Pyrazolones (chemistry), Respiratory Syncytial Viruses (drug effects), Structure-Activity Relationship, Virus Replication (drug effects).
- MESH :
- chemical , chemical synthesis : Antiviral Agents, Nucleosides.
- chemical , chemistry : Pyrazolones.
- chemical , pharmacology : Antiviral Agents, Nucleosides.
- drug effects : Dengue Virus, Hepacivirus, Hepatitis B virus, Influenzavirus A, Middle East Respiratory Syndrome Coronavirus, Respiratory Syncytial Viruses, Virus Replication.
- Drug Design, Humans, Molecular Structure, Structure-Activity Relationship.
Abstract
Dengue (DENV) viral infection is a global public health problem that infrequently develops life threatening diseases such as dengue hemorrhagic fever (DFS) and dengue shock syndrome (DSS). Middle East respiratory syndrome coronavirus (MERS-CoV) is a highly pathogenic human corona virus with 38% fatality rate of infected patients. A series of 4-arylhydrazono-5-trifluoromethyl-pyrazolones, their ribofuranosyl, and 5'-deoxyribofuranosyl nucleosides were synthesized, geometry optimized using Density functional theory (DFT), and evaluated for their antiviral activity. 2-Nitrophenylhydrazonopyra-zolone derivative 5 showed significant activity against MERS-CoV (EC50 = 4.6 μM). The nucleoside analog 8 showed moderate activity against DENV-2 (EC50 = 10 μM), while the activity was abolished with the corresponding 5'-deoxyribonucleoside analogs. The identified hits in this study set this category of compounds for further future optimizations.
DOI: 10.1080/15257770.2019.1591445
PubMed: 30929566
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: 000C53
- to stream PubMed, to step Curation: 000C53
- to stream PubMed, to step Checkpoint: 000C42
- to stream Ncbi, to step Merge: 000853
- to stream Ncbi, to step Curation: 000853
- to stream Ncbi, to step Checkpoint: 000853
- to stream Main, to step Merge: 000D76
- to stream Main, to step Curation: 000D74
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">3-Trifluoromethylpyrazolones derived nucleosides: Synthesis and antiviral evaluation.</title>
<author><name sortKey="Ahmed, Ayman M S" sort="Ahmed, Ayman M S" uniqKey="Ahmed A" first="Ayman M S" last="Ahmed">Ayman M S. Ahmed</name>
<affiliation wicri:level="1"><nlm:affiliation>a Applied Nucleic Acids Research Center , Zagazig University , Zagazig , Egypt.</nlm:affiliation>
<country xml:lang="fr">Égypte</country>
<wicri:regionArea>a Applied Nucleic Acids Research Center , Zagazig University , Zagazig </wicri:regionArea>
<wicri:noRegion>Zagazig </wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Abou Elkhair, Reham A I" sort="Abou Elkhair, Reham A I" uniqKey="Abou Elkhair R" first="Reham A I" last="Abou-Elkhair">Reham A I. Abou-Elkhair</name>
<affiliation wicri:level="1"><nlm:affiliation>a Applied Nucleic Acids Research Center , Zagazig University , Zagazig , Egypt.</nlm:affiliation>
<country xml:lang="fr">Égypte</country>
<wicri:regionArea>a Applied Nucleic Acids Research Center , Zagazig University , Zagazig </wicri:regionArea>
<wicri:noRegion>Zagazig </wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="El Torky, Alaa M" sort="El Torky, Alaa M" uniqKey="El Torky A" first="Alaa M" last="El-Torky">Alaa M. El-Torky</name>
<affiliation wicri:level="1"><nlm:affiliation>a Applied Nucleic Acids Research Center , Zagazig University , Zagazig , Egypt.</nlm:affiliation>
<country xml:lang="fr">Égypte</country>
<wicri:regionArea>a Applied Nucleic Acids Research Center , Zagazig University , Zagazig </wicri:regionArea>
<wicri:noRegion>Zagazig </wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Hassan, Abdalla E A" sort="Hassan, Abdalla E A" uniqKey="Hassan A" first="Abdalla E A" last="Hassan">Abdalla E A. Hassan</name>
<affiliation wicri:level="1"><nlm:affiliation>a Applied Nucleic Acids Research Center , Zagazig University , Zagazig , Egypt.</nlm:affiliation>
<country xml:lang="fr">Égypte</country>
<wicri:regionArea>a Applied Nucleic Acids Research Center , Zagazig University , Zagazig </wicri:regionArea>
<wicri:noRegion>Zagazig </wicri:noRegion>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2019">2019</date>
<idno type="RBID">pubmed:30929566</idno>
<idno type="pmid">30929566</idno>
<idno type="doi">10.1080/15257770.2019.1591445</idno>
<idno type="wicri:Area/PubMed/Corpus">000C53</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000C53</idno>
<idno type="wicri:Area/PubMed/Curation">000C53</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000C53</idno>
<idno type="wicri:Area/PubMed/Checkpoint">000C42</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">000C42</idno>
<idno type="wicri:Area/Ncbi/Merge">000853</idno>
<idno type="wicri:Area/Ncbi/Curation">000853</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">000853</idno>
<idno type="wicri:Area/Main/Merge">000D76</idno>
<idno type="wicri:Area/Main/Curation">000D74</idno>
<idno type="wicri:Area/Main/Exploration">000D74</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">3-Trifluoromethylpyrazolones derived nucleosides: Synthesis and antiviral evaluation.</title>
<author><name sortKey="Ahmed, Ayman M S" sort="Ahmed, Ayman M S" uniqKey="Ahmed A" first="Ayman M S" last="Ahmed">Ayman M S. Ahmed</name>
<affiliation wicri:level="1"><nlm:affiliation>a Applied Nucleic Acids Research Center , Zagazig University , Zagazig , Egypt.</nlm:affiliation>
<country xml:lang="fr">Égypte</country>
<wicri:regionArea>a Applied Nucleic Acids Research Center , Zagazig University , Zagazig </wicri:regionArea>
<wicri:noRegion>Zagazig </wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Abou Elkhair, Reham A I" sort="Abou Elkhair, Reham A I" uniqKey="Abou Elkhair R" first="Reham A I" last="Abou-Elkhair">Reham A I. Abou-Elkhair</name>
<affiliation wicri:level="1"><nlm:affiliation>a Applied Nucleic Acids Research Center , Zagazig University , Zagazig , Egypt.</nlm:affiliation>
<country xml:lang="fr">Égypte</country>
<wicri:regionArea>a Applied Nucleic Acids Research Center , Zagazig University , Zagazig </wicri:regionArea>
<wicri:noRegion>Zagazig </wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="El Torky, Alaa M" sort="El Torky, Alaa M" uniqKey="El Torky A" first="Alaa M" last="El-Torky">Alaa M. El-Torky</name>
<affiliation wicri:level="1"><nlm:affiliation>a Applied Nucleic Acids Research Center , Zagazig University , Zagazig , Egypt.</nlm:affiliation>
<country xml:lang="fr">Égypte</country>
<wicri:regionArea>a Applied Nucleic Acids Research Center , Zagazig University , Zagazig </wicri:regionArea>
<wicri:noRegion>Zagazig </wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Hassan, Abdalla E A" sort="Hassan, Abdalla E A" uniqKey="Hassan A" first="Abdalla E A" last="Hassan">Abdalla E A. Hassan</name>
<affiliation wicri:level="1"><nlm:affiliation>a Applied Nucleic Acids Research Center , Zagazig University , Zagazig , Egypt.</nlm:affiliation>
<country xml:lang="fr">Égypte</country>
<wicri:regionArea>a Applied Nucleic Acids Research Center , Zagazig University , Zagazig </wicri:regionArea>
<wicri:noRegion>Zagazig </wicri:noRegion>
</affiliation>
</author>
</analytic>
<series><title level="j">Nucleosides, nucleotides & nucleic acids</title>
<idno type="eISSN">1532-2335</idno>
<imprint><date when="2019" type="published">2019</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Antiviral Agents (chemical synthesis)</term>
<term>Antiviral Agents (pharmacology)</term>
<term>Dengue Virus (drug effects)</term>
<term>Drug Design</term>
<term>Hepacivirus (drug effects)</term>
<term>Hepatitis B virus (drug effects)</term>
<term>Humans</term>
<term>Influenzavirus A (drug effects)</term>
<term>Middle East Respiratory Syndrome Coronavirus (drug effects)</term>
<term>Molecular Structure</term>
<term>Nucleosides (chemical synthesis)</term>
<term>Nucleosides (pharmacology)</term>
<term>Pyrazolones (chemistry)</term>
<term>Respiratory Syncytial Viruses (drug effects)</term>
<term>Structure-Activity Relationship</term>
<term>Virus Replication (drug effects)</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr"><term>Antiviraux (pharmacologie)</term>
<term>Antiviraux (synthèse chimique)</term>
<term>Conception de médicament</term>
<term>Coronavirus du syndrome respiratoire du Moyen-Orient ()</term>
<term>Hepacivirus ()</term>
<term>Humains</term>
<term>Influenzavirus A ()</term>
<term>Nucléosides (pharmacologie)</term>
<term>Nucléosides (synthèse chimique)</term>
<term>Pyrazolones ()</term>
<term>Relation structure-activité</term>
<term>Réplication virale ()</term>
<term>Structure moléculaire</term>
<term>Virus de l'hépatite B ()</term>
<term>Virus de la dengue ()</term>
<term>Virus respiratoires syncytiaux ()</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="chemical synthesis" xml:lang="en"><term>Antiviral Agents</term>
<term>Nucleosides</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="chemistry" xml:lang="en"><term>Pyrazolones</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="pharmacology" xml:lang="en"><term>Antiviral Agents</term>
<term>Nucleosides</term>
</keywords>
<keywords scheme="MESH" qualifier="drug effects" xml:lang="en"><term>Dengue Virus</term>
<term>Hepacivirus</term>
<term>Hepatitis B virus</term>
<term>Influenzavirus A</term>
<term>Middle East Respiratory Syndrome Coronavirus</term>
<term>Respiratory Syncytial Viruses</term>
<term>Virus Replication</term>
</keywords>
<keywords scheme="MESH" qualifier="pharmacologie" xml:lang="fr"><term>Antiviraux</term>
<term>Nucléosides</term>
</keywords>
<keywords scheme="MESH" qualifier="synthèse chimique" xml:lang="fr"><term>Antiviraux</term>
<term>Nucléosides</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Drug Design</term>
<term>Humans</term>
<term>Molecular Structure</term>
<term>Structure-Activity Relationship</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr"><term>Conception de médicament</term>
<term>Coronavirus du syndrome respiratoire du Moyen-Orient</term>
<term>Hepacivirus</term>
<term>Humains</term>
<term>Influenzavirus A</term>
<term>Pyrazolones</term>
<term>Relation structure-activité</term>
<term>Réplication virale</term>
<term>Structure moléculaire</term>
<term>Virus de l'hépatite B</term>
<term>Virus de la dengue</term>
<term>Virus respiratoires syncytiaux</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Dengue (DENV) viral infection is a global public health problem that infrequently develops life threatening diseases such as dengue hemorrhagic fever (DFS) and dengue shock syndrome (DSS). Middle East respiratory syndrome coronavirus (MERS-CoV) is a highly pathogenic human corona virus with 38% fatality rate of infected patients. A series of 4-arylhydrazono-5-trifluoromethyl-pyrazolones, their ribofuranosyl, and 5'-deoxyribofuranosyl nucleosides were synthesized, geometry optimized using Density functional theory (DFT), and evaluated for their antiviral activity. 2-Nitrophenylhydrazonopyra-zolone derivative 5 showed significant activity against MERS-CoV (EC<sub>50</sub>
= 4.6 μM). The nucleoside analog 8 showed moderate activity against DENV-2 (EC<sub>50</sub>
= 10 μM), while the activity was abolished with the corresponding 5'-deoxyribonucleoside analogs. The identified hits in this study set this category of compounds for further future optimizations.</div>
</front>
</TEI>
<affiliations><list><country><li>Égypte</li>
</country>
</list>
<tree><country name="Égypte"><noRegion><name sortKey="Ahmed, Ayman M S" sort="Ahmed, Ayman M S" uniqKey="Ahmed A" first="Ayman M S" last="Ahmed">Ayman M S. Ahmed</name>
</noRegion>
<name sortKey="Abou Elkhair, Reham A I" sort="Abou Elkhair, Reham A I" uniqKey="Abou Elkhair R" first="Reham A I" last="Abou-Elkhair">Reham A I. Abou-Elkhair</name>
<name sortKey="El Torky, Alaa M" sort="El Torky, Alaa M" uniqKey="El Torky A" first="Alaa M" last="El-Torky">Alaa M. El-Torky</name>
<name sortKey="Hassan, Abdalla E A" sort="Hassan, Abdalla E A" uniqKey="Hassan A" first="Abdalla E A" last="Hassan">Abdalla E A. Hassan</name>
</country>
</tree>
</affiliations>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/CovidV2/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000D74 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000D74 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Sante |area= CovidV2 |flux= Main |étape= Exploration |type= RBID |clé= pubmed:30929566 |texte= 3-Trifluoromethylpyrazolones derived nucleosides: Synthesis and antiviral evaluation. }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:30929566" \ | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \ | NlmPubMed2Wicri -a CovidV2
This area was generated with Dilib version V0.6.33. |